Bladder cancer trials in China

In China 167 Also abroad 626

167 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
9MW2821 Combined With Toripalimab Injection in Subjects With Local Advanced or Metastatic Urothelial Cancer
Where
Beijing
Age
18 years to 80 years
People
100
Run by
Mabwell (Shanghai) Bioscience Co., Ltd.
See details and how to joinNCT06079112
Phase 1/2Not yet taking people in China
SHR-1501 Combined With SHR-2005 for High-Risk Non-Muscle Invasive Bladder Cancer Which is Not Completely Resectable by TURBt
Where
Shanghai
Age
18 years and over
People
58
Run by
Fudan University
See details and how to joinNCT06588179
Phase 3Taking people
9MW2821 in Combination With Toripalimab vs Standard Chemotherapy in Locally Advanced or Metastatic Urothelial Cancer
Where
Shanghai
Age
18 years to 80 years
People
460
Run by
Mabwell (Shanghai) Bioscience Co., Ltd.
See details and how to joinNCT06592326
No phaseTaking people
HER2 Expression of HER2 Affibody-based PET/CT to Predict Response in Bladder Cancer Patients Treated With ADC
Where
Beijing
Age
18 years to 80 years
People
30
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT06548529
Phase 1/2Taking people
To Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravesical Instiliations of Disitamab Vedotin in Patients With High-risk Non-muscular Invasive Bladder Cancer (NMIBC) That Express HER2
Where
Changsha, Chengdu, Guangzhou, Nanjing, Tianjin, Wuhan
Age
18 years to 75 years
People
24
Run by
RemeGen Co., Ltd.
See details and how to joinNCT06378242
Phase 2Taking people
Ivonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and Chemotherapy in Patients With Pancreatic Cancer
Where
Wuhan
Age
18 years and over
People
36 worldwide
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06491472 · EU 2026-525831-17-00
No phaseNot yet taking people in China
Performance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients With Hematuria
Where
Shanghai
Age
18 years to 99 years
People
1,200
Run by
Changhai Hospital
See details and how to joinNCT06469229
No phaseNot yet taking people in China
Neoadjuvant Radiotherapy for High-risk UTUC
Where
Beijing
Age
18 years and over
People
40
Run by
Peking University First Hospital
See details and how to joinNCT06472752
No phaseTaking people
AI Detection of Bladder Tumors Under Endoscopy
Where
Beijing
Age
18 years to 100 years
People
1,000
Run by
Peking Union Medical College Hospital
See details and how to joinNCT06474338
Phase 3Taking people
Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer
Where
Fuzhou
Age
18 years to 75 years
People
76
Run by
Fujian Medical University Union Hospital
See details and how to joinNCT06441110
Phase 2Taking people
DV Combined With Toripalimab for Renal Preservation in Solitary Kidney or Renal Insufficiency or Bilateral Multiple UTUC
Where
Shanghai
Age
18 years and over
People
20
Run by
Fudan University
See details and how to joinNCT06354231
No phaseTaking people
The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection
Where
Nanjing
Age
18 years and over
People
428
Run by
The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06287541
No phaseTaking people
Prognosis of Patients With Upper Tract Urothelial Carcinoma Receiving Kidney-sparing Therapy
Where
Shanghai
Age
18 years to 90 years
People
106
Run by
RenJi Hospital
See details and how to joinNCT06204406
Phase 3Taking people
A Study of RC48-ADC Combined With Toripalimab For First-line Treatment of Urothelial Carcinoma
Where
Beijing
Age
18 years and over
People
452
Run by
RemeGen Co., Ltd.
See details and how to joinNCT05302284
No phaseTaking people
Combined Postoperative Radiotherapy With Kidney Sparing Surgery for Locally Advanced High-risk Ureteral Cancer
Where
Beijing
Age
18 years and over
People
90
Run by
Xuesong Li
See details and how to joinNCT06120387
No phaseNot yet taking people in China
Urinary Continence of Female POPRC and OIN
Where
Guangzhou
Age
55 years to 75 years
People
58
Run by
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT05325216
Phase 2Taking people
Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer
Where
Beijing
Age
18 years and over
People
54
Run by
Peking University First Hospital
See details and how to joinNCT05072600